What Is Hantavirus? Understanding the Virus, Recent 2026 Concerns, and Actual Public Health Risks

Hantavirus is a group of rodent-borne viruses that can cause severe and sometimes fatal disease in humans. In recent weeks, public attention has increased following reports of a hantavirus cluster linked to the cruise ship MV Hondius in the Atlantic Ocean, prompting warnings and public statements from the World Health Organization (WHO). Social media discussions have also fueled concern, with some posts suggesting the virus is “rapidly spreading” globally.

However, current evidence from WHO, the U.S. Centers for Disease Control and Prevention (CDC), and European health agencies indicates that hantavirus outbreaks remain relatively rare and localized. Health authorities continue to assess the global public health risk as low.

This article explains what hantavirus is, how it spreads, what symptoms it causes, recent outbreak developments in 2025–2026, and whether people in Asia-Pacific countries should be concerned.

What Is Hantavirus?

Hantaviruses are viruses that mainly live in rodents (like mice and rats). People are most commonly infected by inhaling dust contaminated with rodent urine, droppings, or saliva. Less often, infection can happen through bites, scratches, or food that has been contaminated.

There are different types (strains) of hantavirus, and each is linked to specific rodent hosts and regions. In North America, the main concern is Sin Nombre virus, which can cause hantavirus pulmonary syndrome (HPS). In many parts of Europe and Asia, other strains (including Hantaan, Seoul, and Puumala viruses) are more often connected to hemorrhagic fever with renal syndrome (HFRS).

Broadly, hantavirus infections appear in two major clinical forms. In the Americas, it more commonly affects the lungs (HPS). In Europe and Asia, it more commonly affects blood vessels and the kidneys (HFRS).

How Does Hantavirus Spread?

The primary route of transmission is contact with infected rodents or their waste products. The CDC notes that infection risk increases in environments where rodents live, particularly when dried droppings or nesting material are disturbed during cleaning.

High-risk activities include cleaning sheds, barns, cabins, attics, garages, storage spaces, or abandoned buildings with rodent infestations. Camping, farming, forestry work, and living in rural or rodent-heavy areas may also increase exposure risk. WHO similarly notes that cases often occur in forests, farms, and rural areas where rodent populations are high.

Most hantavirus strains are not known to spread from person to person. According to WHO, the Andes virus strain found in Argentina and Chile is the main known exception, with limited human-to-human transmission documented in rare cases involving close and prolonged contact, particularly among household members or intimate partners. Health authorities investigating the 2026 MV Hondius cruise ship cluster are examining whether Andes virus may be involved, although investigations remain ongoing and WHO continues to assess the overall public risk as low.

Symptoms and Disease Progression

Hantavirus infections typically begin with flu-like symptoms, making early diagnosis difficult. The incubation period can range from one to eight weeks after exposure. According to WHO and Mayo Clinic, early symptoms may include fever, fatigue, muscle aches, headaches, chills, nausea, vomiting, and abdominal pain.

In hantavirus pulmonary syndrome (HPS), patients may later develop coughing, chest tightness, and severe shortness of breath as fluid accumulates in the lungs. The CDC reports that HPS can become life-threatening very quickly. Mortality rates for HPS are estimated around 35-40%, though some outbreaks have reported higher fatality rates.

In hemorrhagic fever with renal syndrome (HFRS), symptoms may include kidney dysfunction, low blood pressure, internal bleeding, blurred vision, and shock. Severity varies depending on the virus strain, with fatality rates ranging from below 1% to approximately 15%.

Diagnosis and Treatment

Diagnosis is typically based on symptom history, rodent exposure history, and laboratory testing. Blood tests can detect hantavirus antibodies, while PCR-based methods may identify viral genetic material. Doctors also monitor blood abnormalities such as low platelet counts and elevated white blood cell levels.

There is currently no universally approved antiviral cure or widely available vaccine for hantavirus infections in most countries. Treatment is mainly supportive and often requires intensive hospital care. Patients with severe respiratory disease may need oxygen therapy, ventilators, or intensive care unit (ICU) monitoring. Those with kidney complications may require dialysis.

WHO and CDC emphasize that early medical attention significantly improves survival chances.

Source: (CDC, Government of Canada, World Health Organization, ECDC, Reuters)

Historical Outbreaks and Known Cases

Hantavirus first gained major international attention during the 1993 Four Corners outbreak in the southwestern United States, centered around Arizona, New Mexico, Colorado, and Utah. The outbreak was eventually linked to the Sin Nombre virus carried by deer mice. Scientists later connected increased rodent populations during El Niño weather conditions to heightened exposure risks.

According to CDC surveillance data, the United States recorded 864 hantavirus pulmonary syndrome cases between 1993 and 2022, with approximately 94% occurring west of the Mississippi River. Fatality rates remained around 35-36%.

Globally, hantavirus remains more common in Asia and parts of Europe. WHO estimates that most HFRS cases occur in China and Korea, where tens of thousands of infections have historically been reported annually, though incidence has declined over recent decades due to rodent control programs and vaccination efforts. (Source)

Recent Hantavirus Cases in 2025-2026

Recent hantavirus activity in the Americas remains relatively limited but persistent. Reports compiled by regional health monitoring systems documented 229 confirmed cases and 59 deaths across eight countries in the Americas during 2025, representing a fatality rate of roughly 26%.

Argentina, Brazil, Bolivia, Paraguay, and Chile reported some of the highest recent case counts. Paraguay experienced a notable occupational outbreak connected to roadwork activities in Mariscal Estigarribia, while Argentina and Brazil recorded comparatively high fatality rates. PAHO and WHO continue to monitor the regional situation.

In the United States, provisional surveillance data suggest relatively low yearly totals in recent years. Several western states including Arizona, New Mexico, California, and Colorado continue to report sporadic infections associated with rodent exposure.

Health officials in San Diego County also reported the first hantavirus-positive Western harvest mouse of 2026 in January, although no human infections were linked to the finding. (Source: County News Center, Times of San Diego)

The 2026 Cruise Ship Cluster

The most widely discussed recent event involves a hantavirus cluster aboard the expedition cruise ship MV Hondius. In a May 4, 2026 Disease Outbreak News alert, WHO reported seven cases among passengers and crew (two laboratory-confirmed, five suspected) and three deaths.

WHO emphasized that hantavirus remains rare globally and that sustained human-to-human transmission has not been observed outside limited Andes virus situations. The response includes surveillance coordination, laboratory support, epidemiological investigations, contact tracing, and international cooperation under a “One Health” approach. WHO has not declared a global emergency or advised travel restrictions.

The ship traveled from Argentina toward Cape Verde and later toward the Canary Islands. Investigators suspect the Andes virus strain may be involved because this strain is one of the few hantaviruses capable of limited human-to-human transmission. Reuters and WHO both reported that the outbreak remains under investigation, including possible transmission routes and environmental exposure sources.

WHO stated that the overall public health risk remains low and that no broad travel restrictions are recommended. The European Centre for Disease Prevention and Control (ECDC) similarly assessed the risk to Europe as “very low.”

Should Asia-Pacific Countries Be Concerned?

Current evidence suggests that the Asia-Pacific region does not face any unusual hantavirus surge in 2026. Health authorities continue to classify risk levels as stable and manageable.

Countries such as China and South Korea continue to report the highest HFRS burden globally, but incidence rates have generally declined over the past several decades due to improved surveillance, rodent control, and vaccination programs. (Source)

Taiwan’s CDC has reported only a small number of cases in 2026, consistent with previous years. Hong Kong and other regional health agencies continue routine rodent monitoring and public sanitation measures, particularly around ports and urban areas. There is currently no evidence linking the Atlantic cruise ship cluster to wider spread in Asia-Pacific countries.

Experts therefore say there is no reason for public panic in the region. Most cases remain sporadic and strongly associated with direct rodent exposure rather than widespread human transmission.

(Source: IC Journal, ScienceDirect, MDPI, Government of Canada)

Prevention and Public Health Advice

WHO and CDC recommend several practical steps to reduce hantavirus risk. Homes and workplaces should be kept clean and sealed to prevent rodents from entering. Food and trash should be stored securely, and infestations should be addressed promptly.

When cleaning potentially contaminated areas, health authorities recommend wearing gloves and masks, ventilating enclosed spaces beforehand, and using disinfectants or wet-cleaning methods instead of sweeping dry debris.

People experiencing fever, muscle aches, or breathing problems after possible rodent exposure should seek medical attention immediately, as early diagnosis can significantly improve outcomes.

Conclusion

Hantavirus is a serious but relatively rare rodent-borne disease that can cause severe respiratory or kidney illness depending on the strain involved. Although recent headlines surrounding the MV Hondius cruise ship cluster have raised public concern, WHO and international health agencies continue to assess the overall global risk as low.

Most hantavirus infections remain linked to environmental exposure to infected rodents rather than widespread human transmission. Outside the Andes virus strain in South America, person-to-person spread remains extremely uncommon.

For the general public, the most effective protection measures remain practical rodent control, safe cleaning practices, and early medical attention when symptoms appear after potential exposure.